SenseGuard
SenseGuard – A breakthrough respiratory monitoring device incorporating novel nanotechnology-based sensors
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SenseGuard project word cloud
Explore the words cloud of the SenseGuard project. It provides you a very rough idea of what is the project "SenseGuard" about.
Project "SenseGuard" data sheet
The following table provides information about the project.
| Coordinator |
NanoVation-GS
Organization address contact info |
| Coordinator Country | Israel [IL] |
| Project website | https://www.nanovation-gs.com/ |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2019 |
| Duration (year-month-day) | from 2019-05-01 to 2019-09-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | NanoVation-GS | IL (Ramay Ishai) | coordinator | 50˙000.00 |
Map
Project objective
Respiratory rate is a vital sign used to monitor the progression of illness both in hospitals and at home, particularly when dealing with at-risk patients. The continuous monitoring is key for patients with respiratory conditions (i.e. asthma), Chronic Obstructive Pulmonary Diseases (COPD) or pneumonia, with cardiovascular conditions, as well as elderly with comorbidities and prematurely born babies or babies with respiratory conditions.
SenseGuard respiratory monitoring device - is a decision support tool that assists practitioners in better monitoring patients with respiratory conditions like and at risks of deterioration. SenseGuard enables effective generation of alerts to clinical personnel, at the earliest moment following a change in patient’s status, at the hospital or at home. Due to its direct and high-resolution respiratory sensors, SenseGuard is able to continuously monitor pulmonary function on a breath-to-breath basis, unmatched by other technologies. SenseGuardTM can effectively monitor all at-risk patients.
NanoVation is an Israeli SME, founded in 2014, which develops and integrates nanomaterial-based sensors for medical applications and general purposes. Run by an experienced and multi-disciplinary team, NanoVation was granted several EU and non-EU projects, one of which awarded the 2018 Innovation Award by the European Commission. So far, NanoVation has raised and invested more than € 2.5M into the development of SenseGuard. To have it fully projected at a European and global level, NanoVation needs a further investment of €2.2M to complete product development and set up a solid EU value chain.
The proposed work in Phase 1 of the SME instrument fits into the company overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of SenseGuard and its market uptake.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENSEGUARD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SENSEGUARD" are provided by the European Opendata Portal: CORDIS opendata.